Adjunct Therapy with Ketogenic Diet to Infant Bacterial Meningitis

Ketogenic diet in cancer therapy

Neutropenia responsive to ketogenic diet in an infant with GLUT1 deficiency syndrome

Glucose transporter 1 deficiency syndrome (GLUT1-DS1) is a rare and complex congenital metabolic encephalopathy characterized by infantile seizures, movement disorder, delayed development and acquired microcephaly. GLUT1-DS1 is most often caused by a de novo heterozygous mutation of the gene encoding the GLUT1 transporter, SLC2A1. We present an otherwise classical case of GLUT1-DS1 presenting a...

Comparison of Seven Days Antibiotic Therapy with Conventional Treatments of Bacterial Meningitis

The sequelae of acute bacterial meningitis in children who were treated with ampicillin or chloramphenicol for seven days during the period khordad 1366 to Ordibehesht 1369 were assessed prospectively. 165 patients (85 boys and 80 girls) ranged in age from five days to 12 years (mean 31.5 months) were studied. Haemophilus influenza type B was isolated in 65 % , Streptococcus pneumoniae in 25% a...

Implementation of Ketogenic Diet Therapy in Refractory Epilepsies

The Ketogenic Diet (KD) has been used in treatment of epilepsy in mainland China since 2004. Clinical indications of KD include: Glucose Transporter Type 1 (GLUT-1) deficiency, Pyruvate Dehydrogenase Deficiency (PDHD, myoclonus-astatic epilepsy (Doose syndrome), tuberous sclerosis complicated with or without epilepsy, Rett syndrome, Dravet syndrome, infantile spasms, and Landau-Kleffner syndrom...

Ketogenic diet therapy for epilepsy during pregnancy: A case series

PURPOSE Evaluation of ketogenic diet (KD) therapies for seizure control during pregnancy when safety and appropriate management become considerations. Until now, no information has been available on seizure reduction and human pregnancy related outcomes in women treated with KD therapies. METHOD We describe two cases of pregnant women with epilepsy treated with KD therapy either as monotherap...